학술논문

Nivolumab (NIVO) plus chemotherapy (chemo) vs chemo in patients (pts) with EGFR-mutated metastatic non-small cell lung cancer (mNSCLC) with disease progression after EGFR tyrosine kinase inhibitors (TKIs) in CheckMate 722
Document Type
Journal
Source
ANNALS OF ONCOLOGY; NOV 2022, 38 9, pS1561-pS1562, 2p. Supplement: 9
Subject
Language
English
ISSN
15698041